3.74
price up icon2.75%   0.10
after-market After Hours: 3.74
loading
Ironwood Pharmaceuticals Inc stock is traded at $3.74, with a volume of 1.87M. It is up +2.75% in the last 24 hours and down -16.61% over the past month. Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
See More
Previous Close:
$3.64
Open:
$3.67
24h Volume:
1.87M
Relative Volume:
0.44
Market Cap:
$608.42M
Revenue:
$400.57M
Net Income/Loss:
$9.21M
P/E Ratio:
93.50
EPS:
0.04
Net Cash Flow:
$146.36M
1W Performance:
+11.31%
1M Performance:
-16.61%
6M Performance:
+240.00%
1Y Performance:
+151.01%
1-Day Range:
Value
$3.56
$3.795
1-Week Range:
Value
$3.22
$3.795
52-Week Range:
Value
$0.5271
$5.78

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
Name
Ironwood Pharmaceuticals Inc
Name
Phone
617-621-7722
Name
Address
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
Employee
253
Name
Twitter
@ironwoodpharma
Name
Next Earnings Date
2025-02-21
Name
Latest SEC Filings
Name
IRWD's Discussions on Twitter

Compare IRWD vs TAK, ZTS, HLN, TEVA, UTHR

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
IRWD
Ironwood Pharmaceuticals Inc
3.74 592.15M 400.57M 9.21M 146.36M 0.04
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
18.22 57.12B 29.85B 776.90M 4.35B 0.2408
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
125.98 53.16B 9.47B 2.67B 2.28B 6.0218
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.48 47.25B 14.54B 2.22B 2.58B 0.4879
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
32.88 37.59B 17.41B 1.43B 1.00B 1.2182
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
490.21 21.85B 3.13B 1.27B 1.12B 26.39

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-05-26 Upgrade Citizens JMP Mkt Perform → Mkt Outperform
Apr-15-25 Downgrade Jefferies Buy → Hold
Apr-15-25 Downgrade Wells Fargo Overweight → Equal Weight
Apr-14-25 Downgrade Citizens JMP Mkt Outperform → Mkt Perform
Sep-09-24 Initiated Leerink Partners Market Perform
Aug-08-24 Downgrade CapitalOne Overweight → Equal Weight
Jan-17-24 Initiated Craig Hallum Buy
Dec-14-23 Initiated Wells Fargo Overweight
Nov-09-23 Initiated Jefferies Buy
Sep-28-23 Initiated JMP Securities Mkt Outperform
Sep-02-22 Initiated CapitalOne Overweight
Apr-22-22 Initiated Piper Sandler Overweight
Sep-30-20 Downgrade Wells Fargo Overweight → Equal Weight
Jun-17-20 Initiated Northland Capital Outperform
Jul-10-19 Resumed Credit Suisse Neutral
Mar-27-19 Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-25-19 Upgrade H.C. Wainwright Sell → Neutral
Jan-24-19 Upgrade JP Morgan Underweight → Neutral
Nov-07-18 Downgrade Credit Suisse Outperform → Neutral
Nov-07-18 Downgrade JP Morgan Neutral → Underweight
Jul-23-18 Initiated H.C. Wainwright Sell
May-09-18 Downgrade Morgan Stanley Equal-Weight → Underweight
Jan-05-18 Downgrade BofA/Merrill Buy → Underperform
Dec-06-17 Downgrade Mizuho Buy → Neutral
Jul-21-17 Downgrade JP Morgan Overweight → Neutral
May-03-17 Initiated Wells Fargo Outperform
Apr-07-17 Reiterated Mizuho Buy
Feb-22-17 Reiterated Barclays Equal Weight
Nov-04-16 Reiterated Mizuho Buy
Oct-24-16 Reiterated Wedbush Neutral
Oct-10-16 Reiterated Mizuho Buy
Sep-27-16 Reiterated WallachBeth Hold
View All

Ironwood Pharmaceuticals Inc Stock (IRWD) Latest News

pulisher
09:46 AM

US Stocks Recap: Does Ironwood Pharmaceuticals Inc have declining or rising EPSJuly 2025 Catalysts & Risk Controlled Daily Trade Plans - baoquankhu1.vn

09:46 AM
pulisher
Mar 02, 2026

Gains Report: Can Ironwood Pharmaceuticals Inc stock double in the next yearPrice Action & Target Return Focused Stock Picks - baoquankhu1.vn

Mar 02, 2026
pulisher
Mar 02, 2026

IRWD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 02, 2026
pulisher
Mar 02, 2026

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

IRONWOOD PHARMACEUTICALS INC (IRWD) Earnings History & Surprises - ChartMill

Mar 02, 2026
pulisher
Feb 28, 2026

IRWD Should I Buy - Intellectia AI

Feb 28, 2026
pulisher
Feb 27, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Cut to "Hold" at Zacks Research - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Plays Key Role In Nasdaq Futures Healthcare - Kalkine Media

Feb 27, 2026
pulisher
Feb 27, 2026

Jefferies Maintains Hold on Ironwood Pharmaceuticals (IRWD) Feb 26, 2026 - Meyka

Feb 27, 2026
pulisher
Feb 26, 2026

A Look At Ironwood Pharmaceuticals (IRWD) Valuation After Q4 2025 Results And 2026 Revenue Guidance - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Posts Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Ironwood Pharmaceuticals: Downgrading On Pipeline Setback And Extended Timeline For Apraglutide - Seeking Alpha

Feb 26, 2026
pulisher
Feb 26, 2026

Jefferies raises Ironwood Pharmaceuticals stock price target on Linzess outlook - Investing.com Canada

Feb 26, 2026
pulisher
Feb 26, 2026

IRWD Q4 Earnings and Revenues Fall Shy of Estimates, Stock Tanks - Finviz

Feb 26, 2026
pulisher
Feb 26, 2026

IRWD: Analyst Raises Price Target and Maintains Rating | IRWD St - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 9.5% on Analyst Upgrade - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Price Target Raised to $10.00 at Citizens Jmp - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

GSA Capital Partners LLP Has $405,000 Stock Holdings in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Feb 26, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals (IRWD) Margin Rebound Challenges Bearish Narratives Despite Softer Revenue - simplywall.st

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood (IRWD) Q4 2025 Earnings Call Transcript - The Globe and Mail

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals Q4 2025 Earnings Call Transcript - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals Balances Growth Plans With Pricing Risks - TipRanks

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals Inc (IRWD) Q4 2025 Earnings Call Highli - GuruFocus

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood (NASDAQ: IRWD) chief auto-sells 36,492 shares for tax withholding - Stock Titan

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals (IRWD) officer sells shares to cover tax withholding - Stock Titan

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:IRWD) 2026-02-25 - Seeking Alpha

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals Faces Tumultuous Week Amid Market Volatility - StocksToTrade

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap DownWhat's Next? - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Earnings call transcript: Ironwood Pharmaceuticals Q4 2025 misses forecasts, shares drop - Investing.com Australia

Feb 25, 2026
pulisher
Feb 25, 2026

IRWD: 2026 guidance targets >$1.1B LINZESS sales and pivotal apraglutide Phase III launch - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Form 8K Ironwood Pharmaceuticals Inc For: 25 February By Investing.com - Investing.com Australia

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals (IRWD) Targets Over $300M Adjusted EBIT - GuruFocus

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood (IRWD) Reports Q4 Revenue Below Expectations - GuruFocus

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals, Inc. Reiterates Earnings Guidance for the Year 2026 - marketscreener.com

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals officially released its financial report for the fourth quarter and full year of 2025 today. - Bitget

Feb 25, 2026
pulisher
Feb 25, 2026

IRONWOOD PHARMACEUTICALS ($IRWD) Releases Q4 2025 Earnings - Quiver Quantitative

Feb 25, 2026
pulisher
Feb 25, 2026

Form 8K Ironwood Pharmaceuticals Inc For: 25 February - Investing.com India

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook - The AI Journal

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Ironwood Pharmaceuticals (IRWD) posts 2025 results and raises 2026 EBITDA outlook - Stock Titan

Feb 25, 2026
pulisher
Feb 24, 2026

Ironwood: Q4 Financial Overview - Bitget

Feb 24, 2026
pulisher
Feb 24, 2026

Insights into Ironwood Pharmaceuticals's Upcoming Earnings - Benzinga

Feb 24, 2026
pulisher
Feb 24, 2026

Rate Hike: Can Ironwood Pharmaceuticals Inc stock double in the next year2025 Key Lessons & Long-Term Growth Stock Strategies - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 23, 2026

What's in Store for These 5 Medical Companies This Earnings Season? - TradingView

Feb 23, 2026
pulisher
Feb 22, 2026

Ironwood Pharmaceuticals Faces Operational Challenges Following Third-Quarter Earnings - StocksToTrade

Feb 22, 2026
pulisher
Feb 21, 2026

IRWD’s Strategic Moves Amid Market Dynamics - timothysykes.com

Feb 21, 2026
pulisher
Feb 20, 2026

Insider sale notice: Ironwood Pharmaceuticals (NASDAQ: IRWD) lists RSU shares - Stock Titan

Feb 20, 2026

Ironwood Pharmaceuticals Inc Stock (IRWD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Ironwood Pharmaceuticals Inc Stock (IRWD) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
John Minardo
Chief Legal Officer
Feb 23 '26
Sale
3.81
17,439
66,443
382,939
Shetzline Michael
SVP, CMO, Head-Res&Drug
Feb 23 '26
Sale
3.81
15,570
59,322
538,437
Gaskins Tammi L
Chief Commercial Officer
Feb 24 '26
Sale
3.66
11,239
41,135
213,738
Gaskins Tammi L
Chief Commercial Officer
Feb 23 '26
Sale
3.81
10,287
39,193
224,977
MCCOURT Thomas A
Chief Executive Officer
Feb 24 '26
Sale
3.66
103,526
378,905
1,489,002
MCCOURT Thomas A
Chief Executive Officer
Feb 23 '26
Sale
3.81
94,757
361,024
1,592,528
Martini Gregory S.
Chief Financial Officer
Feb 24 '26
Sale
3.66
11,457
41,933
160,601
Martini Gregory S.
Chief Financial Officer
Feb 23 '26
Sale
3.81
10,487
39,955
172,058
Silver Ronald
Principal Accounting Officer
Feb 24 '26
Sale
3.66
12,621
46,193
252,636
Silver Ronald
Principal Accounting Officer
Feb 23 '26
Sale
3.81
11,552
44,013
265,257
drug_manufacturers_specialty_generic RDY
$14.32
price up icon 0.49%
$24.73
price down icon 0.60%
drug_manufacturers_specialty_generic RGC
$25.25
price up icon 4.46%
$132.25
price up icon 0.53%
$14.86
price down icon 0.34%
$487.88
price down icon 2.11%
Cap:     |  Volume (24h):